Article
USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells
7 Apr 2019
Abstract excerpt
The mesenchymal (MES) subtype of glioblastoma (GBM) stem cells (GSCs) represents a subpopulation of cancer cells that are notorious for their highly aggressive nature and resistance to conventional therapy. Aldehyde dehydrogenase 1A3 (ALDH1A3) has been recently suggested as a key determinant for the maintenance of MES features of GSCs. However, the mechanisms underpinning aberrant ALDH1A3 expression remain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
